Home/Filings/4/0001493152-22-033640
4//SEC Filing

King-Jones Heidy 4

Accession 0001493152-22-033640

CIK 0001695357other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 9:28 PM ET

Size

6.5 KB

Accession

0001493152-22-033640

Insider Transaction Report

Form 4
Period: 2022-11-22
King-Jones Heidy
Chief Legal Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-22+90,000300,000 total
    Exercise: $11.23From: 2022-11-22Exp: 2030-08-03Common Stock, par value $0.0001 (90,000 underlying)
Footnotes (3)
  • [F1]As previously reported on a Form 4 filed on August 3, 2020, on August 3, 2020 the Reporting Person was granted a stock option for 300,000 shares of Common Stock, 120,000 of which option shares vest in four equal annual installments commencing on August 3, 2021 and 180,000 of which option shares vest upon completion of certain performance milestones. This amount represents the vesting of 90,000 of the 180,000 performance option shares on November 22, 2022 upon the satisfaction of certain performance milestones. This Form 4 is being filed solely to report the vesting of such previously reported 90,000 option shares.
  • [F2]The stock options were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.
  • [F3]Represents the 120,000 time-based option shares referred to in footnote (1) plus the 30,000 vested performance option shares which vested August 3, 2021 plus 60,000 vested performance option shares which vested March 22, 2022 plus the 90,000 vested performance option shares referred to in footnote (1).

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001794898

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 9:28 PM ET
Size
6.5 KB